Prelude Therapeutics Incorporated Profile Avatar - Palmy Investing

Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select sol…

Biotechnology
US, Wilmington [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of PRLD's Analysis
CIK: 1678660 CUSIP: 74065P101 ISIN: US74065P1012 LEI: - UEI: -
Secondary Listings
PRLD has no secondary listings inside our databases.